Table 1.

Anterograde Tracer Injection Sites

Location	Experiment	Layer	Size (µm)
Perirhinal Area 36
Rostral area 36	45P	III–VI	400
Rostral area 36	54P	V–VI	400
Midrostrocaudal area 36	62B	II–V	400
Midrostrocaudal area 36	90P	V–VI	300
Midrostrocaudal area 36	128B	II–VI	400
Caudal area 36	27P	II–VI	300
Ventral area 36	129B	II–V	300
Ventral area 36	1130B	III–VI	400
Perirhinal Area 35
Rostral area 35	24P	III–VI	300
Caudal area 35	16B	II–V	400
Postrhinal
Rostral	39P	I–VI	400
Rostrodorsal	83B	IV–VI	500
Dorsal	134B	I–VI	500
Caudal	40P	III–VI	500
Caudal	558B	I–III	300
Entorhinal LEA
Rostral LEA, L	21P	III–V	300
Rostral LEA, L	57P	II–VI	400
Rostral LEA, L	261B	I–III	400
Rostral LEA, L	127B	III–VI	500
Midrostrocaudal LEA, L	66P	II–III	300
Midrostrocaudal LEA, I	60B	II–V	700
Caudomedial LEA, I	70P	II–IV	400
Caudal LEA, M	656B	II–V	500
Entorhinal MEA
Lateral MEA, L	28P	III–VI	300
Caudal MEA, L	652B	II–VI	300
Medial MEA, L	68P	II–VI	500
Medial MEA, L	41P	II–VI	200
Caudomedial MEA, L/I	3653B	II–VI	300
Medial MEA, M	654B	II–VI	400

Anterograde injections sites are suffixed with a P or a B for PHA-L and BDA, respectively.

¹Experiment 130B encroached slightly on area 35.

²Experiment 61B encroached slightly on superficial layers of area 36.

³Experiment 653B was located on the border between the lateral and intermediate bands.

Abbreviations: L, lateral dentate gyrus-projecting band; I, intermediate band; M, medial band.